MEGHAN PAGE: Open Payments
NPI 1841454469 · DANBURY, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$189 in 9 payments from 7 companies in 2025. Trend: 2023 $158 · 2024 $357 · 2025 $189
Food & beverage: $189
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 2 | $39 |
| ABBVIE INC. | 2 | $37 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $31 |
| Myriad Genetic Laboratories, Inc. | 1 | $29 |
| SOBI, INC | 1 | $24 |
| Genentech USA, Inc. | 1 | $15 |
| TAIHO ONCOLOGY, INC. | 1 | $15 |
Products named: VENCLEXTA, FRUZAQLA, MYRISK, Vonjo, KISQALI, SCEMBLIX, Polivy, LONSURF.
Industry payments across CT — which companies pay providers there.
